Coagulation
Australian registry will grow evidence for anticoagulation in the obese
A lack of validated on-therapy ranges for the novel oral anticoagulants (NOACs) contributes to the difficulty in managing obese patients with conditions such as pulmonary embolism (PE) or deep vein thrombosis (DVT), a haematology meeting has heard.
In addition, there is...
A lack of validated on-therapy ranges for the novel oral anticoagulants (NOACs) contributes to the difficulty in managing obese patients...